Description
Introduction
Datamonitor surveyed 199 primary care physicians and specialists on the prevalence of key complications and comorbidities in type 2 diabetes patients. Reported prevalences vary widely among the seven major markets. Key opinion leader insight and secondary research show how treatment choices are affected by patient conditions including renal impairment, obesity and frail old age.
Features And Benefits
• Analyze country-specific physician insight on patient complications and comorbidities
• Seek out opportunities for treatment of key patient subsets
• Contextualize survey data using new key opinion leader insight
• Understand how treatment choices are affected by conditions such as obesity or kidney dysfunction.
Highlights
As well as complications and comorbidities, other patient characteristics affect physicians’ treatment choices. An important factor is old age accompanied by lack of independence. Physicians may treat diabetes patients in this cohort with only one basal insulin injection per day, for simplicity and to avoid hypoglycemia.
Reported prevalence of overweight and obesity combined in type 2 diabetes patients ranges from 70% of diagnosed type 2 diabetes patients in Italy to 85% in Germany. Obesity means that physicians may prefer weight-reducing GLP-1 agonists to options like insulin and sulfonylureas, that lead to weight gain.
Renal insufficiency at some level affects a significant proportion of type 2 diabetes patients, and is one of the key drivers for therapy change. Physicians see different drug classes, and different drugs within classes, as suitable for treating patients with low kidney function.
Your Key Questions Answered
• Delve into primary data from 199 seven major market physicians on prevalence and time to development of microvascular and macrovascular complications.
• Analyze reported prevalence of comorbidities in type 2 diabetes, and differences among the seven major markets.
• Use key opinion leader insight to identify patient characteristics that affect antidiabetic treatment choices.
Table of Contents
Executive Summary
Strategic scoping and focus
Datamonitor key findings
Diabetes reports in the seven major markets
Published diabetes reports
OVERVIEW
Catalyst
Summary
Introduction
Comorbidities
Complications
PATIENT CHARACTERISTICS AND TYPE 2 DIABETES TREATMENT
Old age in type 2 diabetes treatment
Prevalence of old age in type 2 diabetes
Effect of old age in type 2 diabetes treatment
COMORBIDITIES IN TYPE 2 DIABETES
[Missing title]
Comorbidity estimates vary by physician type
Obesity
Overweight and obesity rates in type 2 diabetes
Effect of obesity on type 2 diabetes treatment
Hypertension
Dyslipidemia
Total cholesterol levels
Low HDL levels
Hypertriglyceridemia
Effect of dyslipidemia and hypertension on type 2 diabetes patient management
Hypertension and dyslipidemia and choice of antidiabetic drug
Comorbidities and the overall drug burden in type 2 diabetes patients
COMPLICATIONS IN TYPE 2 DIABETES
[Missing title]
Complication estimates vary by physician type
Microvascular complications in type 2 diabetes
Nephropathy
Effect of nephropathy on type 2 diabetes treatment
Retinopathy
Neuropathy
Macrovascular complications in type 2 diabetes
Myocardial infarction
Stroke
Effect of macrovascular complications on type 2 diabetes treatment
VARIATIONS AMONG THE SEVEN MAJOR MARKETS
[Missing title]
Screening programs and detection
BIBLIOGRAPHY
Journal papers
Other sources
Datamonitor reports
Appendix
Datamonitor’s Type 2 Diabetes Physician Survey
Contributing experts
Report methodology
